Clinical Trials
Byondis Initiates Phase I Study of Antibody-Drug Conjugate SYD1875
Byondis B.V. (formerly Synthon Biopharmaceuticals B.V.) announced that the first cancer patients have started treatment with its investigational antibody-drug conjugate (ADC) SYD1875.
The First-in-Human Dose-Escalation and...
Clinical Trials
Qu Biologics Initiates Phase 2 Study to Assess Activation of Anti-cancer Immune Response in Colon Cancer
Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, is pleased to...
Clinical Trials
DSG and Bestat Partner in Building COVID-19 Clinical Trials in Singapore
DSG, Inc., a global leader of eClinical software solutions and services for the life sciences industry along with their CRO partner, Bestat Pharmaservices Corp. (Bestat)...
Clinical Trials
SAB Biotherapeutics Announces First Participant Dosed In Phase 1 Clinical Trial Of SAB-185 For The Treatment And Prevention Of COVID-19
SAB Biotherapeutics (SAB), a clinical stage biopharmaceutical company developing a novel immunotherapy platform to produce specifically targeted, high potency, fully human polyclonal antibodies without the...
Clinical Trials
Novavax Initiates Efficacy Trial of COVID-19 Vaccine in South Africa
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced the beginning of a Phase 2b clinical trial in South Africa...
Clinical Trials
Phesi Powers Data-Driven Clinical Trials Through Addition of New Country Selection Functionality to ClinSite
Phesi, a data-driven provider of clinical development analytics products and solutions, announced a new country selection functionality has been added to ClinSite, its platform to...
Clinical Trials
Zydus Cadila announces completion of dosing in Phase I clinical trial of ZyCoV-D
Zydus Cadila, an innovation driven global pharmaceutical company focused on discovering and developing NCEs, Novel Biologicals, Biosimilars and Vaccines, announced that its plasmid DNA vaccine...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.